Long-Term PF-06651600 for the Treatment of Alopecia Areata
- Status
- COMPLETED
- Phase
- PHASE3
Clinical Trials Related to Pfizer
Related studies linked through entity extraction aliases.
Bioavailability Study of PF-06651600 Formulations in Healthy Participants
- Status
- COMPLETED
- Phase
- PHASE1
A Multicenter, Safety and Efficacy Study of Taliglucerase Alfa in Subjects With Type 3 Gaucher Disease
- Status
- COMPLETED
- Phase
- PHASE4
CLassification of Axial SpondyloarthritiS Inception Cohort
- Status
- COMPLETED
- Phase
- N/A
Changes of Depression After First-year of Tofacitinib in RA Patients
- Status
- COMPLETED
- Phase
- N/A
Inotuzumab Ozogamicin and Chemotherapy in Treating Patients With Recurrent or Refractory B-cell Acute Lymphoblastic Leukemia
- Status
- COMPLETED
- Phase
- PHASE1
Evaluation of Talazoparib, a PARP Inhibitor, in Patients With Somatic BRCA Mutant Metastatic Breast Cancer: Genotyping Based Clinical Trial
- Status
- RECRUITING
- Phase
- PHASE2
A 16 Week Study to Evaluate the Efficacy and Safety of PF-06882961 in Adults With Type 2 Diabetes Mellitus
- Status
- COMPLETED
- Phase
- PHASE2
IDentification of Factors Predictive of Tofacitinib's Survival in Patient With Rheumatoid Arthritis
- Status
- COMPLETED
- Phase
- N/A
Evaluate Taste and Relative Bioavailability of Two Microsphere Formulations of Crizotinib in Healthy Participants
- Status
- COMPLETED
- Phase
- PHASE1
Comparative Analysis of Outcomes Among Patients Initiating Xeljanz in Combination With Oral MTX Who Withdraw MTX Versus Continue MTX
- Status
- COMPLETED
- Phase
- N/A
Singe Dose Study of PF- 06946860 in Healthy Adult Japanese Participants
- Status
- COMPLETED
- Phase
- PHASE1
Talazoparib for Cohesin-Mutated AML and MDS With Excess Blasts
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Study of Binimetinib With Encorafenib in Adults With Recurrent BRAF V600-Mutated HGG
- Status
- TERMINATED
- Phase
- PHASE2
Avelumab With Binimetinib, Sacituzumab Govitecan, or Liposomal Doxorubicin in Treating Stage IV or Unresectable, Recurrent Triple Negative Breast Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Alternative Schedule Study For VLA15, a Vaccine Candidate Against Lyme Borreliosis
- Status
- COMPLETED
- Phase
- PHASE2
A Double-blind Study to Assess 2 Doses of an Investigational Product for 16 Weeks in Participants With Non-alcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus
- Status
- COMPLETED
- Phase
- PHASE2
Neoadjuvant Hormonal Therapy Plus Palbociclib in Operable, Hormone Sensitive and HER2-Negative Primary Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Comparative Analysis of Outcomes Among Patients Treated With Xeljanz vs Biologics
- Status
- COMPLETED
- Phase
- N/A
TALAVE: Induction Talazoparib Followed by Combination of Talazoparib and Avelumab in Advanced Breast Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2